Mesenchymal stem cell therapy for corneal diseases

References

• Kimbrel EA, Lanza R. Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies. Regen Med. 2015;10:99–102.
   PubMed Web of Science ®Google Scholar
• Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79:214–221.
   PubMed Web of Science ®Google Scholar
• Li F, Zhao SZ. Mesenchymal stem cells: potential role in corneal wound repair and transplantation. World J Stem Cells. 2014;6:296–304.
   PubMedGoogle Scholar
• Reinhard T, Spelsberg H, Henke L, et al. Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency. Ophthalmology. 2004;111:775–782.
   PubMed Web of Science ®Google Scholar
• Mills RA, Coster DJ, Williams KA. Effect of immunosuppression on outcome measures in a model of rat limbal transplantation. Invest Ophthalmol Vis Sci. 2002;43:647–655.
   PubMed Web of Science ®Google Scholar
• Basu S, Hertsenberg AJ, Funderburgh ML, et al. Human limbal biopsy-derived stromal stem cells prevent corneal scarring. Sci Transl Med. 2014;6:266ra172.
   PubMed Web of Science ®Google Scholar
• Parekh M, Ferrari S, Sheridan C, et al. Concise review: an update on the culture of human corneal endothelial cells for transplantation. Stem Cells Transl Med. 2016;5:258–264.
   PubMed Web of Science ®Google Scholar
• Mendicino M, Bailey AM, Wonnacott K, et al. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell. 2014;14:141–145.
   PubMed Web of Science ®Google Scholar
• Du Y, Funderburgh ML, Mann MM, et al. Multipotent stem cells in human corneal stroma. Stem Cells. 2005;23:1266–1275.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Ishikawa F, Sonoda KH, et al. Characterization and distribution of bone marrow-derived cells in mouse cornea. Invest Ophthalmol Vis Sci. 2005;46:497–503.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41–49.
   PubMed Web of Science ®Google Scholar
• Singh V, Jaini R, Torricelli AA, et al. TGFbeta and PDGF-B signaling blockade inhibits myofibroblast development from both bone marrow-derived and keratocyte-derived precursor cells in vivo. Exp Eye Res. 2014;121:35–40.
   PubMed Web of Science ®Google Scholar
• Singh V, Jaini R, Torricelli AA, et al. A method to generate enhanced GFP+ chimeric mice to study the role of bone marrow-derived cells in the eye. Exp Eye Res. 2013;116:366–370.
   PubMed Web of Science ®Google Scholar
• Sosnova M, Bradl M, Forrester JV. CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers. Stem Cells. 2005;23:507–515.
   PubMed Web of Science ®Google Scholar
• Guo Y, Lubbert M, Engelhardt M. CD34- hematopoietic stem cells: current concepts and controversies. Stem Cells. 2003;21:15–20.
   Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147.
   PubMed Web of Science ®Google Scholar
• Majors AK, Boehm CA, Nitto H, et al. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res. 1997;15:546–557.
   PubMed Web of Science ®Google Scholar
• Guillot PV, Gotherstrom C, Chan J, et al. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells. 2007;25:646–654.
   PubMed Web of Science ®Google Scholar
• Housman TS, Lawrence N, Mellen BG, et al. The safety of liposuction: results of a national survey. Dermatol Surg. 2002;28:971–978.
   PubMed Web of Science ®Google Scholar
• Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med. 2005;54:132–141.
   PubMed Web of Science ®Google Scholar
• Lin G, Garcia M, Ning H, et al. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008;17:1053–1063.
   PubMed Web of Science ®Google Scholar
• Fuentes-Julian S, Arnalich-Montiel F, Jaumandreu L, et al. Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome. PLoS One. 2015;10:e0117945.
   PubMed Web of Science ®Google Scholar
• Ranganathan K, Lakshminarayanan V. Stem cells of the dental pulp. Indian J Dent Res. 2012;23:558.
   PubMedGoogle Scholar
• Gronthos S, Brahim J, Li W, et al. Stem cell properties of human dental pulp stem cells. J Dent Res. 2002;81:531–535.
   PubMed Web of Science ®Google Scholar
• Gomes JA, Geraldes MB, Melo GB, et al. Corneal reconstruction with tissue-engineered cell sheets composed of human immature dental pulp stem cells. Invest Ophthalmol Vis Sci. 2010;51:1408–1414.
   PubMed Web of Science ®Google Scholar
• El OR, Beroud J, Stoltz JF, et al. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev. 2014;20:523–544.
   PubMed Web of Science ®Google Scholar
• Joyce NC, Harris DL, Markov V, et al. Potential of human umbilical cord blood mesenchymal stem cells to heal damaged corneal endothelium. Mol Vis. 2012;18:547–564.
   PubMed Web of Science ®Google Scholar
• Di NM, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838–3843.
   PubMed Web of Science ®Google Scholar
• Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101:3722–3729.
   PubMed Web of Science ®Google Scholar
• Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood. 2005;105:2214–2219.
   PubMed Web of Science ®Google Scholar
• Groh ME, Maitra B, Szekely E, et al. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol. 2005;33:928–934.
   PubMed Web of Science ®Google Scholar
• Batten P, Sarathchandra P, Antoniw JW, et al. Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng. 2006;12:2263–2273.
   PubMedGoogle Scholar
• Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005;105:4120–4126.
   PubMed Web of Science ®Google Scholar
• Djouad F, Charbonnier LM, Bouffi C, et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells. 2007;25:2025–2032.
   PubMed Web of Science ®Google Scholar
• Oh JY, Kim MK, Shin MS, et al. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells. 2008;26:1047–1055.
   PubMed Web of Science ®Google Scholar
• Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol. 2000;44:367–408.
   PubMed Web of Science ®Google Scholar
• Pinnamaneni N, Funderburgh JL. Concise review: stem cells in the corneal stroma. Stem Cells. 2012;30:1059–1063.
   PubMed Web of Science ®Google Scholar
• Eghrari AO, Riazuddin SA, Gottsch JD. Overview of the cornea: structure, function, and development. Prog Mol Biol Transl Sci. 2015;134:7–23.
   PubMed Web of Science ®Google Scholar
• Treacy O, Fahy G, Ritter T, et al. Corneal immunosuppressive mechanisms, Anterior Chamber-Associated Immune Deviation (ACAID) and their role in allograft rejection. Methods Mol Biol. 2016;1371:205–214.
   PubMedGoogle Scholar
• Niederkorn JY. Corneal transplantation and immune privilege. Int Rev Immunol. 2013;32:57–67.
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. Immune privilege in the anterior chamber of the eye. Crit Rev Immunol. 2002;22:13–46.
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol. 2006;7:354–359.
   PubMed Web of Science ®Google Scholar
• Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3:879–889.
   PubMed Web of Science ®Google Scholar
• Masli S, Vega JL. Ocular immune privilege sites. Methods Mol Biol. 2011;677:449–458.
   PubMedGoogle Scholar
• Davanger M, Evensen A. Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature. 1971;229:560–561.
   PubMed Web of Science ®Google Scholar
• Dua HS, Shanmuganathan VA, Powell-Richards AO, et al. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. Br J Ophthalmol. 2005;89:529–532.
   PubMed Web of Science ®Google Scholar
• Shortt AJ, Secker GA, Munro PM, et al. Characterization of the limbal epithelial stem cell niche: novel imaging techniques permit in vivo observation and targeted biopsy of limbal epithelial stem cells. Stem Cells. 2007;25:1402–1409.
   PubMed Web of Science ®Google Scholar
• Vereb Z, Poliska S, Albert R, et al. Role of human corneal stroma-derived mesenchymal-like stem cells in corneal immunity and wound healing. Sci Rep. 2016;6:26227.
   PubMed Web of Science ®Google Scholar
• Dua HS, Miri A, Alomar T, et al. The role of limbal stem cells in corneal epithelial maintenance: testing the dogma. Ophthalmology. 2009;116:856–863.
   PubMed Web of Science ®Google Scholar
• Polisetty N, Fatima A, Madhira SL, et al. Mesenchymal cells from limbal stroma of human eye. Mol Vis. 2008;14:431–442.
   PubMed Web of Science ®Google Scholar
• Xie HT, Chen SY, Li GG, et al. Isolation and expansion of human limbal stromal niche cells. Invest Ophthalmol Vis Sci. 2012;53:279–286.
   PubMed Web of Science ®Google Scholar
• Soma T, Hayashi R, Sugiyama H, et al. Maintenance and distribution of epithelial stem/progenitor cells after corneal reconstruction using oral mucosal epithelial cell sheets. PLoS One. 2014;9:e110987.
   Google Scholar
• Sangwan VS, Matalia HP, Vemuganti GK, et al. Clinical outcome of autologous cultivated limbal epithelium transplantation. Indian J Ophthalmol. 2006;54:29–34.
   PubMedGoogle Scholar
• Sangwan VS, Basu S, Vemuganti GK, et al. Clinical outcomes of xeno-free autologous cultivated limbal epithelial transplantation: a 10-year study. Br J Ophthalmol. 2011;95:1525–1529.
   PubMed Web of Science ®Google Scholar
• Pellegrini G, Traverso CE, Franzi AT, et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet. 1997;349:990–993.
   PubMed Web of Science ®Google Scholar
• Shortt AJ, Secker GA, Notara MD, et al. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol. 2007;52:483–502.
   PubMed Web of Science ®Google Scholar
• Basu S, Sureka SP, Shanbhag SS, et al. Simple limbal epithelial transplantation: long-term clinical outcomes in 125 cases of unilateral chronic ocular surface burns. Ophthalmology. 2016;123:1000–1010.
   PubMed Web of Science ®Google Scholar
• Bhalekar S, Sangwan VS, Basu S. Growth of corneal epithelial cells over in situ therapeutic contact lens after Simple Limbal Epithelial Transplantation (SLET). BMJ Case Rep. 2013. doi:10.1136/bcr-2013-009113.
   Google Scholar
• Sangwan VS, Basu S, MacNeil S, et al. Simple limbal epithelial transplantation (SLET): a novel surgical technique for the treatment of unilateral limbal stem cell deficiency. Br J Ophthalmol. 2012;96:931–934.
   PubMed Web of Science ®Google Scholar
• Eslani M, Baradaran-Rafii A, Ahmad S. Cultivated limbal and oral mucosal epithelial transplantation. Semin Ophthalmol. 2012;27:80–93.
   PubMed Web of Science ®Google Scholar
• Satake Y, Higa K, Tsubota K, et al. Long-term outcome of cultivated oral mucosal epithelial sheet transplantation in treatment of total limbal stem cell deficiency. Ophthalmology. 2011;118:1524–1530.
   PubMed Web of Science ®Google Scholar
• Basu S, Taneja M, Narayanan R, et al. Short-term outcome of Boston type 1 keratoprosthesis for bilateral limbal stem cell deficiency. Indian J Ophthalmol. 2012;60:151–153.
   PubMed Web of Science ®Google Scholar
• Sejpal K, Yu F, Aldave AJ. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea. 2011;30:1187–1194.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Inatomi T, Sotozono C, et al. Ocular surface reconstruction using stem cell and tissue engineering. Prog Retin Eye Res. 2016;51:187–207.
   PubMed Web of Science ®Google Scholar
• Tseng SC. Concept and application of limbal stem cells. Eye (Lond). 1989;3(Pt 2):141–157.
   PubMed Web of Science ®Google Scholar
• Tseng SC. Regulation and clinical implications of corneal epithelial stem cells. Mol Biol Rep. 1996;23:47–58.
   PubMed Web of Science ®Google Scholar
• Singh V, Shukla S, Ramachandran C, et al. Science and art of cell-based ocular surface regeneration. Int Rev Cell Mol Biol. 2015;319:45–106.
   PubMed Web of Science ®Google Scholar
• Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2012;20:14–20.
   PubMed Web of Science ®Google Scholar
• Roddy GW, Oh JY, Lee RH, et al. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. Stem Cells. 2011;29:1572–1579.
   PubMed Web of Science ®Google Scholar
• Ye J, Yao K, Kim JC. Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing. Eye (Lond). 2006;20:482–490.
   PubMed Web of Science ®Google Scholar
• Zhang L, Coulson-Thomas VJ, Ferreira TG, et al. Mesenchymal stem cells for treating ocular surface diseases. BMC Ophthalmol. 2015;15 Suppl 1:155.
   PubMed Web of Science ®Google Scholar
• Sejpal K, Ali MH, Maddileti S, et al. Cultivated limbal epithelial transplantation in children with ocular surface burns. JAMA Ophthalmol. 2013;131:731–736.
   PubMed Web of Science ®Google Scholar
• Amescua G, Atallah M, Nikpoor N, et al. Modified simple limbal epithelial transplantation using cryopreserved amniotic membrane for unilateral limbal stem cell deficiency. Am J Ophthalmol. 2014;158:469–475.
   PubMed Web of Science ®Google Scholar
• Holan V, Pokorna K, Prochazkova J, et al. Immunoregulatory properties of mouse limbal stem cells. J Immunol. 2010;184:2124–2129.
   PubMed Web of Science ®Google Scholar
• Ma Y, Xu Y, Xiao Z, et al. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells. 2006;24:315–321.
   PubMed Web of Science ®Google Scholar
• Holan V, Trosan P, Cejka C, et al. A comparative study of the therapeutic potential of mesenchymal stem cells and limbal epithelial stem cells for ocular surface reconstruction. Stem Cells Transl Med. 2015;4:1052–1063.
   PubMed Web of Science ®Google Scholar
• Funderburgh JL, Mann MM, Funderburgh ML. Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. J Biol Chem. 2003;278:45629–45637.
   PubMed Web of Science ®Google Scholar
• Jester JV, Barry-Lane PA, Cavanagh HD, et al. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996;15:505–516.
   PubMed Web of Science ®Google Scholar
• Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004;11:67–115.
   PubMed Web of Science ®Google Scholar
• Dandona L, Ragu K, Janarthanan M, et al. Indications for penetrating keratoplasty in India. Indian J Ophthalmol. 1997;45:163–168.
   PubMedGoogle Scholar
• Han KE, Choi SI, Chung WS, et al. Extremely varied phenotypes in granular corneal dystrophy type 2 heterozygotes. Mol Vis. 2012;18:1755–1762.
   PubMed Web of Science ®Google Scholar
• Kamiya K, Kobashi H, Igarashi A, et al. Effect of light scattering and higher-order aberrations on visual performance in eyes with granular corneal dystrophy. Sci Rep. 2016;6:24677.
   PubMed Web of Science ®Google Scholar
• Mashima Y, Konishi M, Nakamura Y, et al. Severe form of juvenile corneal stromal dystrophy with homozygous R124H mutation in the keratoepithelin gene in five Japanese patients. Br J Ophthalmol. 1998;82:1280–1284.
   PubMed Web of Science ®Google Scholar
• Abazi Z, Magarasevic L, Grubisa I, et al. Individual phenotypic variances in a family with Avellino corneal dystrophy. BMC Ophthalmol. 2013;13:30.
   PubMed Web of Science ®Google Scholar
• Konishi M, Yamada M, Nakamura Y, et al. Varied appearance of cornea of patients with corneal dystrophy associated with R124H mutation in the BIGH3 gene. Cornea. 1999;18:424–429.
   PubMed Web of Science ®Google Scholar
• Du Y, Sundarraj N, Funderburgh ML, et al. Secretion and organization of a cornea-like tissue in vitro by stem cells from human corneal stroma. Invest Ophthalmol Vis Sci. 2007;48:5038–5045.
   PubMed Web of Science ®Google Scholar
• Du Y, Carlson EC, Funderburgh ML, et al. Stem cell therapy restores transparency to defective murine corneas. Stem Cells. 2009;27:1635–1642.
   PubMed Web of Science ®Google Scholar
• Omoto M, Katikireddy KR, Rezazadeh A, et al. Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation. Invest Ophthalmol Vis Sci. 2014;55:6631–6638.
   PubMed Web of Science ®Google Scholar
• Harkin DG, Foyn L, Bray LJ, et al. Concise reviews: can mesenchymal stromal cells differentiate into corneal cells? A systematic review of published data. Stem Cells. 2015;33:785–791.
   PubMed Web of Science ®Google Scholar